MTVA stock news · MetaVia Inc.
Get alerts for MTVA
Follow MetaVia Inc. (MTVA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MTVAFree on the App Store and Google Play, or on the web.
MetaVia Announces Positive Interim Phase 1 Data for DA-1726
Good for MTVAMetaVia reported 13.5% lower body weight and 68% lower liver fat versus placebo. These findings favor MTVA, though Phase 2 is planned for the second half of 2027.
MetaVia Inc. says it has a new Chief Medical Officer.
NeutralMetaVia named Sarah Kaplan Browne its chief medical officer, but the filing gives no details about changes to its work or results. The news does not change the company's outlook.